• Receptor Transporter Protein 4 (RTP4) in the hypothalamus is involved in the development of antinociceptive tolerance to Morphine
  (Fujita W et al., 2022)
• SLITRK1-mediated noradrenergic projection suppression in the neonatal prefrontal cortex
  (Hatayama M et al., 2022) (1/2)
• A revertant of Homo sapiens-specific residue in SLITRK1 alters its protein function
  (Hatayama M et al., 2022) (2/2)
• Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
  (Katayama K et al., 2022)
• Leucine-Rich Repeats and Transmembrane Domain 2 controls protein sorting in the striatal projection system and its deficiency causes disturbances in motor responses and monoamine dynamics
  (Ichise M et al., 2022)
• Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice
  （Maekawa R et al., 2021）
• Sphingosine 1-phosphate signaling is involved in impaired blood-brain barrier function in ischemia-reperfusion injury.
  （Nakagawa S et al., 2019）
• Identification and characterization of novel conserved domains in metazoan Zic proteins
  （Tohmonda T et al., 2018）
• Zic family – Evolution, Development and Disease
  （Aruga J Ed, 2018）
• Link between the causative genes of holoprosencephaly: Zic2 directly regulates Tgif1 expression
  （Ishiguro A et al., 2018）
• Autism-like behaviours and enhanced memory formation and synaptic plasticity in Lrfn2/SALM1-deficient mice.
  （Morimura N et al., 2017）
• Elfn1 recruits presynaptic　mGluR7 in trans and its loss results in seizures.
  （Tomioka N et al., 2014）
• Hepatocyte growth factor enhances the barrier function in primary cultures of rat brain microvascular endothelial cells.
  （Yamada N et al., 2014）
• Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
  （Takeshita T et al., 2014）
• Rines E3 Ubiquitin Ligase Regulates MAO-A Levels and Emotional Responses.
  （Kabayama et al., 2013）
• SLITRK6　mutations cause myopia and deafness in humans and mice.
  （Tekin et al., 2013）